Brands that make unhealthy foods will be able to get round the government's junk food advertising ban if their adverts don't ...

Trumponomics, inflation, artificial intelligence, the changing media landscape, and the Elon Musk effect — these were the big themes covered at the annual event.

Obesity and visceral fat are associated with measures of amyloid burden in the brain among cognitively normal midlife ...

Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made ...

The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...

NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...

Health-care companies were flat, hovering near all-time highs amid optimism about the biotech and obesity-drug niches. In the first head-to-head test, Eli Lilly's Zepbound obesity drug helped people ...

Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

A virtual simulation of interactions between complex biological membranes and alternative bisphenols indicates that BPF and ...

Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...

A new study presented at the Radiological Society of North America annual meeting explored the link between obesity and the ...